BMY logo

Bristol-Myers Squibb Company (BMY) EBIT

Annual EBIT:

$9.66B+$1.19B(+14.00%)
December 31, 2024

Summary

  • As of today, BMY annual earnings before interest & taxes is $9.66 billion, with the most recent change of +$1.19 billion (+14.00%) on December 31, 2024.
  • During the last 3 years, BMY annual EBIT has risen by +$118.00 million (+1.24%).
  • BMY annual EBIT is now at all-time high.

Performance

BMY EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

Quarterly EBIT:

$0.00-$4.12B(-100.00%)
September 30, 2025

Summary

  • As of today, BMY quarterly earnings before interest & taxes is $0.00, with the most recent change of -$4.12 billion (-100.00%) on September 30, 2025.
  • Over the past year, BMY quarterly EBIT has dropped by -$2.29 billion (-100.00%).
  • BMY quarterly EBIT is now -100.00% below its all-time high of $4.12 billion, reached on June 30, 2025.

Performance

BMY Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

TTM EBIT:

$10.17B-$2.29B(-18.37%)
September 30, 2025

Summary

  • As of today, BMY TTM earnings before interest & taxes is $10.17 billion, with the most recent change of -$2.29 billion (-18.37%) on September 30, 2025.
  • Over the past year, BMY TTM EBIT has increased by +$1.81 billion (+21.65%).
  • BMY TTM EBIT is now -18.37% below its all-time high of $12.46 billion, reached on June 30, 2025.

Performance

BMY TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

BMY EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+14.0%-100.0%+21.6%
3Y3 Years+1.2%-100.0%+7.3%
5Y5 Years+50.0%-100.0%+158.5%

BMY EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+14.0%-100.0%at low-18.4%+35.0%
5Y5-Yearat high+115.0%-100.0%at low-18.4%+158.5%
All-TimeAll-Timeat high+1996.4%-100.0%+100.0%-18.4%+365.6%

BMY EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
$0.00(-100.0%)
$10.17B(-18.4%)
Jun 2025
-
$4.12B(+16.9%)
$12.46B(+14.0%)
Mar 2025
-
$3.52B(+39.1%)
$10.92B(+22.2%)
Dec 2024
$9.66B(+14.0%)
$2.53B(+10.6%)
$8.94B(+6.9%)
Sep 2024
-
$2.29B(-11.5%)
$8.36B(+2.3%)
Jun 2024
-
$2.58B(+68.3%)
$8.18B(+8.5%)
Mar 2024
-
$1.53B(-21.4%)
$7.53B(-10.9%)
Dec 2023
$8.47B(-8.6%)
$1.95B(-7.2%)
$8.45B(-6.4%)
Sep 2023
-
$2.10B(+8.3%)
$9.03B(+3.0%)
Jun 2023
-
$1.94B(-20.8%)
$8.77B(-7.8%)
Mar 2023
-
$2.45B(-3.0%)
$9.51B(-2.6%)
Dec 2022
$9.27B(-2.8%)
$2.53B(+37.5%)
$9.77B(+3.1%)
Sep 2022
-
$1.84B(-31.6%)
$9.47B(+1.2%)
Jun 2022
-
$2.69B(-0.8%)
$9.37B(+13.7%)
Mar 2022
-
$2.71B(+21.4%)
$8.23B(+6.7%)
Dec 2021
$9.54B(+112.4%)
$2.23B(+29.0%)
$7.72B(+24.2%)
Sep 2021
-
$1.73B(+11.2%)
$6.22B(+6.3%)
Jun 2021
-
$1.56B(-29.1%)
$5.85B(+11.8%)
Mar 2021
-
$2.20B(+200.5%)
$5.23B(+32.0%)
Dec 2020
$4.49B(-30.2%)
$731.00M(-46.5%)
$3.96B(+0.8%)
Sep 2020
-
$1.37B(+45.5%)
$3.93B(-10.0%)
Jun 2020
-
$939.00M(+1.2%)
$4.37B(-19.8%)
Mar 2020
-
$928.00M(+32.4%)
$5.45B(-13.6%)
Dec 2019
$6.44B(+0.7%)
$701.00M(-61.1%)
$6.30B(-12.4%)
Sep 2019
-
$1.80B(-10.7%)
$7.19B(+1.8%)
Jun 2019
-
$2.02B(+13.2%)
$7.07B(+26.0%)
Mar 2019
-
$1.78B(+12.1%)
$5.61B(+7.5%)
Dec 2018
$6.39B(+22.0%)
$1.59B(-5.2%)
$5.22B(+12.0%)
Sep 2018
-
$1.68B(+200.0%)
$4.66B(+15.2%)
Jun 2018
-
$559.00M(-59.9%)
$4.04B(-18.9%)
Mar 2018
-
$1.39B(+35.4%)
$4.99B(+0.5%)
Dec 2017
$5.24B(+1.2%)
$1.03B(-3.3%)
$4.96B(+0.6%)
Sep 2017
-
$1.06B(-29.2%)
$4.93B(-5.2%)
Jun 2017
-
$1.50B(+9.6%)
$5.20B(+2.6%)
Mar 2017
-
$1.37B(+37.4%)
$5.07B(+2.0%)
Dec 2016
$5.18B(+31.5%)
$997.00M(-25.3%)
$4.97B(+13.2%)
Sep 2016
-
$1.33B(-2.4%)
$4.39B(+15.8%)
Jun 2016
-
$1.37B(+7.8%)
$3.79B(+45.2%)
Mar 2016
-
$1.27B(+203.6%)
$2.61B(+5.2%)
Dec 2015
$3.94B(+25.6%)
$418.00M(-43.3%)
$2.48B(-15.9%)
Sep 2015
-
$737.00M(+294.1%)
$2.95B(+3.1%)
Jun 2015
-
$187.00M(-83.6%)
$2.87B(-17.8%)
Mar 2015
-
$1.14B(+28.3%)
$3.49B(+11.4%)
Dec 2014
$3.13B(+0.2%)
$889.00M(+37.2%)
$3.13B(-4.3%)
Sep 2014
-
$648.00M(-19.9%)
$3.27B(-6.2%)
Jun 2014
-
$809.00M(+3.2%)
$3.49B(+2.2%)
Mar 2014
-
$784.00M(-23.9%)
$3.41B(+5.8%)
Dec 2013
$3.13B(-26.6%)
$1.03B(+19.1%)
$3.22B(+12.2%)
Sep 2013
-
$865.00M(+18.0%)
$2.87B(+11.9%)
Jun 2013
-
$733.00M(+23.0%)
$2.57B(-14.1%)
Mar 2013
-
$596.00M(-12.2%)
$2.99B(-29.4%)
Dec 2012
$4.27B(-36.8%)
$679.00M(+21.3%)
$4.24B(-18.0%)
Sep 2012
-
$560.00M(-51.5%)
$5.17B(-18.9%)
Jun 2012
-
$1.16B(-37.3%)
$6.37B(-8.7%)
Mar 2012
-
$1.84B(+14.7%)
$6.98B(+3.3%)
Dec 2011
$6.75B(+10.0%)
$1.61B(-9.0%)
$6.75B(+2.4%)
Sep 2011
-
$1.76B(0.0%)
$6.60B(+2.4%)
Jun 2011
-
$1.76B(+9.1%)
$6.44B(+3.6%)
Mar 2011
-
$1.62B(+11.6%)
$6.22B(+1.8%)
Dec 2010
$6.14B(+21.6%)
$1.45B(-9.9%)
$6.11B(+19.6%)
Sep 2010
-
$1.61B(+4.5%)
$5.11B(-0.7%)
Jun 2010
-
$1.54B(+2.1%)
$5.14B(-1.9%)
Mar 2010
-
$1.51B(+234.4%)
$5.25B(+3.2%)
Dec 2009
$5.05B(+3.5%)
$451.00M(-72.6%)
$5.08B(-12.2%)
Sep 2009
-
$1.65B(+0.4%)
$5.79B(+6.3%)
Jun 2009
-
$1.64B(+22.1%)
$5.45B(+9.2%)
Mar 2009
-
$1.34B(+16.3%)
$4.99B(+1.5%)
Dec 2008
$4.88B(+29.4%)
$1.16B(-11.5%)
$4.91B(+11.4%)
Sep 2008
-
$1.31B(+10.7%)
$4.41B(+4.6%)
Jun 2008
-
$1.18B(-7.2%)
$4.22B(+3.1%)
Mar 2008
-
$1.27B(+94.5%)
$4.09B(+11.0%)
Dec 2007
$3.77B(+42.6%)
$654.00M(-41.2%)
$3.69B(+12.8%)
Sep 2007
-
$1.11B(+5.6%)
$3.27B(+19.8%)
Jun 2007
-
$1.05B(+21.7%)
$2.73B(+0.1%)
Mar 2007
-
$866.00M(+268.5%)
$2.73B(-4.5%)
Dec 2006
$2.64B(-36.0%)
$235.00M(-59.1%)
$2.85B(-19.8%)
Sep 2006
-
$574.00M(-45.4%)
$3.56B(-11.0%)
Jun 2006
-
$1.05B(+5.6%)
$4.00B(-2.3%)
Mar 2006
-
$995.00M(+6.0%)
$4.09B(-0.7%)
Dec 2005
$4.13B
$939.00M(-7.5%)
$4.13B(+9.4%)
Sep 2005
-
$1.01B(-11.4%)
$3.77B(-4.1%)
DateAnnualQuarterlyTTM
Jun 2005
-
$1.15B(+11.8%)
$3.93B(+12.3%)
Mar 2005
-
$1.02B(+75.2%)
$3.50B(-3.4%)
Dec 2004
$4.70B(-7.2%)
$585.00M(-50.3%)
$3.63B(-10.8%)
Sep 2004
-
$1.18B(+64.5%)
$4.07B(-4.5%)
Jun 2004
-
$716.00M(-37.7%)
$4.26B(-11.3%)
Mar 2004
-
$1.15B(+12.2%)
$4.80B(+0.1%)
Dec 2003
$5.06B(+22.9%)
$1.02B(-25.1%)
$4.79B(+22.5%)
Sep 2003
-
$1.37B(+8.7%)
$3.91B(+13.4%)
Jun 2003
-
$1.26B(+10.0%)
$3.45B(+2.5%)
Mar 2003
-
$1.14B(+690.1%)
$3.37B(+13.9%)
Dec 2002
$4.12B(-20.2%)
$144.80M(-84.0%)
$2.96B(-30.9%)
Sep 2002
-
$904.00M(-23.1%)
$4.28B(+6.4%)
Jun 2002
-
$1.18B(+60.3%)
$4.02B(-6.5%)
Mar 2002
-
$733.00M(-50.0%)
$4.30B(-17.6%)
Dec 2001
$5.16B(-13.8%)
$1.47B(+127.1%)
$5.22B(-2.6%)
Sep 2001
-
$646.00M(-55.6%)
$5.36B(-14.1%)
Jun 2001
-
$1.46B(-12.0%)
$6.24B(-0.3%)
Mar 2001
-
$1.66B(+3.1%)
$6.26B(+0.1%)
Dec 2000
$5.99B(+2.3%)
$1.61B(+5.2%)
$6.26B(+2.6%)
Sep 2000
-
$1.53B(+3.6%)
$6.10B(+0.1%)
Jun 2000
-
$1.47B(-10.7%)
$6.09B(+3.2%)
Mar 2000
-
$1.65B(+14.2%)
$5.90B(+3.7%)
Dec 1999
$5.85B(+14.3%)
$1.45B(-4.7%)
$5.69B(+2.3%)
Sep 1999
-
$1.52B(+17.9%)
$5.57B(+3.2%)
Jun 1999
-
$1.29B(-10.8%)
$5.39B(+2.3%)
Mar 1999
-
$1.44B(+9.4%)
$5.27B(+2.9%)
Dec 1998
$5.12B(+15.4%)
$1.32B(-2.0%)
$5.12B(+5.0%)
Sep 1998
-
$1.35B(+15.6%)
$4.88B(+3.2%)
Jun 1998
-
$1.16B(-9.9%)
$4.73B(+2.9%)
Mar 1998
-
$1.29B(+20.0%)
$4.60B(+3.6%)
Dec 1997
$4.44B(+12.3%)
$1.08B(-9.9%)
$4.44B(+3.0%)
Sep 1997
-
$1.20B(+15.9%)
$4.31B(+3.3%)
Jun 1997
-
$1.03B(-8.9%)
$4.17B(+2.7%)
Mar 1997
-
$1.13B(+19.5%)
$4.06B(+2.8%)
Dec 1996
$3.95B(+9.3%)
$948.00M(-10.6%)
$3.95B(+2.2%)
Sep 1996
-
$1.06B(+14.8%)
$3.87B(+2.7%)
Jun 1996
-
$923.00M(-9.7%)
$3.77B(+1.6%)
Mar 1996
-
$1.02B(+18.4%)
$3.71B(+2.5%)
Dec 1995
$3.62B(+12.2%)
$863.00M(-9.9%)
$3.62B(+3.3%)
Sep 1995
-
$958.00M(+11.1%)
$3.50B(+2.5%)
Jun 1995
-
$862.00M(-7.5%)
$3.42B(+2.7%)
Mar 1995
-
$932.00M(+24.6%)
$3.33B(+3.2%)
Dec 1994
$3.22B(+11.0%)
$748.00M(-14.4%)
$3.22B(+25.3%)
Sep 1994
-
$874.00M(+13.2%)
$2.57B(+2.0%)
Jun 1994
-
$772.00M(-6.8%)
$2.52B(+2.8%)
Mar 1994
-
$828.00M(+744.9%)
$2.45B(+2.1%)
Dec 1993
$2.90B(+48.1%)
$98.00M(-88.1%)
$2.40B(+18.0%)
Sep 1993
-
$823.00M(+16.9%)
$2.04B(+0.7%)
Jun 1993
-
$704.00M(-9.5%)
$2.02B(+1.8%)
Mar 1993
-
$778.00M(+390.3%)
$1.99B(+1.4%)
Dec 1992
$1.96B(-29.1%)
-$268.00M(-133.2%)
$1.96B(-30.3%)
Sep 1992
-
$808.00M(+20.8%)
$2.81B(+0.9%)
Jun 1992
-
$669.00M(-10.9%)
$2.79B(-0.9%)
Mar 1992
-
$751.00M(+28.8%)
$2.81B(+1.7%)
Dec 1991
$2.77B(+15.8%)
$583.00M(-25.6%)
$2.77B(+4.2%)
Sep 1991
-
$784.00M(+12.8%)
$2.65B(+2.6%)
Jun 1991
-
$695.00M(-1.3%)
$2.59B(+3.6%)
Mar 1991
-
$704.00M(+49.2%)
$2.50B(+4.6%)
Dec 1990
$2.39B(+23.3%)
$472.00M(-34.1%)
$2.39B(+162.4%)
Sep 1990
-
$716.00M(+18.2%)
-$3.83B(-72.1%)
Jun 1990
-
$606.00M(+1.8%)
-$2.23B(-279.0%)
Mar 1990
-
$595.00M(+110.4%)
-$587.00M(-154.2%)
Dec 1989
$1.94B(+46.9%)
-$5.75B(-347.7%)
$1.08B(-50.4%)
Sep 1989
-
$2.32B(+3.4%)
$2.19B(+6.0%)
Jun 1989
-
$2.24B(-0.9%)
$2.06B(+7.5%)
Mar 1989
-
$2.27B(+148.8%)
$1.92B(+8.4%)
Dec 1988
$1.32B(+6.7%)
-$4.64B(-311.5%)
$1.77B(-20.0%)
Sep 1988
-
$2.20B(+4.5%)
$2.21B(+16.1%)
Jun 1988
-
$2.10B(-0.8%)
$1.91B(+12.5%)
Mar 1988
-
$2.12B(+150.4%)
$1.69B(+15.5%)
Dec 1987
$1.24B(+39.6%)
-$4.20B(-322.4%)
$1.47B(-74.1%)
Sep 1987
-
$1.89B(0.0%)
$5.67B(+50.0%)
Jun 1987
-
$1.89B(0.0%)
$3.78B(+100.0%)
Mar 1987
-
$1.89B
$1.89B
Dec 1986
$886.30M(+17.1%)
-
-
Dec 1985
$757.10M(+5.2%)
-
-
Dec 1984
$719.80M(+11.5%)
-
-
Dec 1983
$645.70M(+13.3%)
-
-
Dec 1982
$569.80M(+9.4%)
-
-
Dec 1981
$520.70M(+13.0%)
-
-
Dec 1980
$460.70M
-
-

FAQ

  • What is Bristol-Myers Squibb Company annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company annual EBIT year-on-year change?
  • What is Bristol-Myers Squibb Company quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company quarterly EBIT year-on-year change?
  • What is Bristol-Myers Squibb Company TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company TTM EBIT year-on-year change?

What is Bristol-Myers Squibb Company annual earnings before interest & taxes?

The current annual EBIT of BMY is $9.66B

What is the all-time high annual EBIT for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high annual earnings before interest & taxes is $9.66B

What is Bristol-Myers Squibb Company annual EBIT year-on-year change?

Over the past year, BMY annual earnings before interest & taxes has changed by +$1.19B (+14.00%)

What is Bristol-Myers Squibb Company quarterly earnings before interest & taxes?

The current quarterly EBIT of BMY is $0.00

What is the all-time high quarterly EBIT for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high quarterly earnings before interest & taxes is $4.12B

What is Bristol-Myers Squibb Company quarterly EBIT year-on-year change?

Over the past year, BMY quarterly earnings before interest & taxes has changed by -$2.29B (-100.00%)

What is Bristol-Myers Squibb Company TTM earnings before interest & taxes?

The current TTM EBIT of BMY is $10.17B

What is the all-time high TTM EBIT for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high TTM earnings before interest & taxes is $12.46B

What is Bristol-Myers Squibb Company TTM EBIT year-on-year change?

Over the past year, BMY TTM earnings before interest & taxes has changed by +$1.81B (+21.65%)
On this page